OTC regulation in Asia: where are we now?

IFLR is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

OTC regulation in Asia: where are we now?

Regulators across the Asia-Pacific are preparing to implement rules for clearing OTC derivatives transactions. But many jurisdictions are stumbling on legal issues

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login
Gift this article